Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis

International Journal of Rheumatic Diseases

Volumn 18, Issue 5, 2015, Pages 533-540

  Cheng, Fa Juan ^a   Zhou, Xu Jie ^a   Zhao, Yan Feng ^a   Zhao, Ming Hui ^a   Zhang, Hong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Human neutrophil peptide; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

ALPHA DEFENSIN; BIOLOGICAL MARKER; HUMAN NEUTROPHIL PEPTIDE 1-3; UNCLASSIFIED DRUG; HUMAN NEUTROPHIL PEPTIDE 1; HUMAN NEUTROPHIL PEPTIDE 2; HUMAN NEUTROPHIL PEPTIDE 3;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR TRAP; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LEUKOCYTE COUNT; LIPOID NEPHROSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOPSY; BLOOD; CASE CONTROL STUDY; KIDNEY; LUPUS NEPHRITIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; ALPHA-DEFENSINS; BIOMARKERS; BIOPSY; CASE-CONTROL STUDIES; EXTRACELLULAR TRAPS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PROGNOSIS;

EID: 84930976620     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12433     Document Type: Article

References (26)

1. Ganz T, Selsted ME, Szklarek D et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76, 1427-35.
2. Yang D, Chen Q, Chertov O, Oppenheim JJ (2000) Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 68, 9-14.
3. Brogden KA, Heidari M, Sacco RE et al. (2003) Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 18, 95-9.
4. Zhou XJ, Cheng FJ, Lv JC et al. (2012) Higher DEFB4 genomic copy number in SLE and ANCA-associated small vasculitis. Rheumatology (Oxford) 51, 992-5.
5. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365, 2110-21.
6. Adhya Z, Borozdenkova S, Karim MY (2011) The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. Nephrol Dial Transplant 26, 3273-80.
7. Bennett L, Palucka AK, Arce E et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197, 711-23.
8. Lande R, Ganguly D, Facchinetti V et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3, 19r-73r.
9. Hakkim A, Furnrohr BG, Amann K et al. (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 107, 9813-8.
10. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40, 1725.
11. Weening JJ, D'Agati VD, Schwartz MM et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15, 241-50.
12. Weening JJ, D'Agati VD, Schwartz MM et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65, 521-30.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35, 630-40.
14. Ma YC, Zuo L, Chen JH et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17, 2937-44.
15. Vordenbaumen S, Timm D, Bleck E et al. (2011) Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis. Rheumatol Int 31, 1251-4.
16. Garcia-Romo GS, Caielli S, Vega B et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3, 20r-73r.
17. Kessenbrock K, Krumbholz M, Schonermarck U et al. (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15, 623-5.
18. Lin AM, Rubin CJ, Khandpur R et al. (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187, 490-500.
19. Brinkmann V, Reichard U, Goosmann C et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303, 1532-5.
20. Villanueva E, Yalavarthi S, Berthier CC et al. (2011) Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 187, 538-52.
21. Vordenbaumen S, Fischer-Betz R, Timm D et al. (2010) Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Lupus 19, 1648-53.
22. Sthoeger ZM, Bezalel S, Chapnik N, Asher I, Froy O (2009) High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology 127, 116-22.
23. Panneer D, Antony PT, Negi VS (2013) Q222R polymorphism in DNAse I gene is a risk factor for nephritis in South Indian SLE patients. Lupus 22, 996-1000.
24. Yasutomo K, Horiuchi T, Kagami S et al. (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28, 313-4.
25. Shin HD, Park BL, Kim LH, Lee HS, Kim TY, Bae SC (2004) Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet 13, 2343-50.
26. Leffler J, Martin M, Gullstrand B et al. (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188, 3522-31.